These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20688878)

  • 1. Transforming growth factor-beta1-mediated activation of NF-kappaB contributes to enhanced ADAM-12 expression in mammary carcinoma cells.
    Ray A; Dhar S; Ray BK
    Mol Cancer Res; 2010 Sep; 8(9):1261-70. PubMed ID: 20688878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoblasts-derived TGF-beta1 enhance motility and integrin upregulation through Akt, ERK, and NF-kappaB-dependent pathway in human breast cancer cells.
    Wei YY; Chen YJ; Hsiao YC; Huang YC; Lai TH; Tang CH
    Mol Carcinog; 2008 Jul; 47(7):526-37. PubMed ID: 18161870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells.
    Lin CC; Chiang LL; Lin CH; Shih CH; Liao YT; Hsu MJ; Chen BC
    Eur J Pharmacol; 2007 Apr; 560(2-3):101-9. PubMed ID: 17307160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression.
    Sovak MA; Arsura M; Zanieski G; Kavanagh KT; Sonenshein GE
    Cell Growth Differ; 1999 Aug; 10(8):537-44. PubMed ID: 10470853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
    Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
    Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta1 increases cell migration and beta1 integrin up-regulation in human lung cancer cells.
    Fong YC; Hsu SF; Wu CL; Li TM; Kao ST; Tsai FJ; Chen WC; Liu SC; Wu CM; Tang CH
    Lung Cancer; 2009 Apr; 64(1):13-21. PubMed ID: 18771813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
    Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.
    Bendinelli P; Matteucci E; Maroni P; Desiderio MA
    Mol Cancer Res; 2009 Aug; 7(8):1328-41. PubMed ID: 19671685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
    Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta1 inhibits NF-kappaB activity through induction of IkappaB-alpha expression in human salivary gland cells: a possible mechanism of growth suppression by TGF-beta1.
    Azuma M; Motegi K; Aota K; Yamashita T; Yoshida H; Sato M
    Exp Cell Res; 1999 Jul; 250(1):213-22. PubMed ID: 10388535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
    Gupta V; Yeo G; Kawakubo H; Rangnekar V; Ramaswamy P; Hayashida T; MacLaughlin DT; Donahoe PK; Maheswaran S
    Cancer Res; 2007 Mar; 67(6):2747-56. PubMed ID: 17363596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
    Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
    Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of CK2 activity by TGF-beta1 promotes IkappaB-alpha protein stabilization and apoptosis of immortalized hepatocytes.
    Cavin LG; Romieu-Mourez R; Panta GR; Sun J; Factor VM; Thorgeirsson SS; Sonenshein GE; Arsura M
    Hepatology; 2003 Dec; 38(6):1540-51. PubMed ID: 14647065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma Cells.
    Farina AR; Masciulli MP; Tacconelli A; Cappabianca L; De Santis G; Gulino A; Mackay AR
    Cell Growth Differ; 2002 Aug; 13(8):343-54. PubMed ID: 12193473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblast-derived TGF-beta1 stimulates IL-8 release through AP-1 and NF-kappaB in human cancer cells.
    Fong YC; Maa MC; Tsai FJ; Chen WC; Lin JG; Jeng LB; Yang RS; Fu WM; Tang CH
    J Bone Miner Res; 2008 Jun; 23(6):961-70. PubMed ID: 18435575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
    Mori N; Morishita M; Tsukazaki T; Yamamoto N
    Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
    Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
    Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation.
    Monteleone G; Mann J; Monteleone I; Vavassori P; Bremner R; Fantini M; Del Vecchio Blanco G; Tersigni R; Alessandroni L; Mann D; Pallone F; MacDonald TT
    J Biol Chem; 2004 Feb; 279(6):3925-32. PubMed ID: 14600158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
    Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
    Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation.
    Haller D; Holt L; Kim SC; Schwabe RF; Sartor RB; Jobin C
    J Biol Chem; 2003 Jun; 278(26):23851-60. PubMed ID: 12672795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.